肥胖中的电解质失衡和代谢紧急情况:机制和临床影响
Iulia Najette Crintea1,2, Alexandru Cristian Cindrea1,2, Ovidiu Alexandru Mederle1,2
1Department of Surgery, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
Diseases (Basel, Switzerland)
|March 26, 2025
概括
电解质失衡在肥胖中很常见,增加心脏和脏问题的风险. 管理包括监测,饮食改变,补充剂和生活方式调整,以改善代谢健康.
科学领域:
- 内分泌学 在内分泌学.
- 腎臟病學 (nephrology) 是一種醫學.
- 代谢健康 代谢健康
背景情况:
- 电解质失衡在与肥胖相关的代谢功能障碍中至关重要.
- 它们有助于心血管疾病,功能障碍和代谢紧急情况.
- 原因包括胰岛素抵抗,炎症,荷尔蒙失调和功能障碍.
研究的目的:
- 为了探索肥胖中电解质障碍的病理生理学.
- 检查它们对液体平衡,酸状态和代谢健康的影响.
- 审查有效的管理和预防策略.
主要方法:
- 文献综述侧重于病理生理学和肥胖中电解质失衡的管理.
- 分析诸如胰岛素耐药性和功能障碍之类的促成因素.
- 评估治疗策略,包括监测,补充和生活方式干预措施.
主要成果:
- 肥胖相关的电解质障碍包括保留,耗和/缺乏.
- 这些不平衡会加剧高血压,代谢酸和胰岛素抵抗.
- 有效的管理需要个性化监测,饮食中的限制,和的纠正,以及针对RAAS的药物.
结论:
- 对肥胖个体来说,管理电解质失衡至关重要,以防止严重的代谢并发症.
- 结合饮食修改,减肥和优化水分的综合方法是关键.
- 个性化,多学科的护理对于最佳的结果至关重要.
相关概念视频
Overview of Lipid Metabolism
7.0K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
7.0K
Obesity
1.6K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.6K
Disorder of Water Balance
2.8K
Water balance disorders are medical conditions that occur when there is a deviation from the body's water volume or osmolarity, disrupting normal homeostasis and leading todehydration, hypotonic hydration, hyperhydration, edema, or water intoxication.
Dehydration
Dehydration occurs when the body loses fluids (particularly water).
Causes:
The major causes of dehydration include excessive sweating, fever, vomiting, diarrhea, and diuresis.
Signs and Symptoms:
Symptoms primarily include intense...
Dehydration
Dehydration occurs when the body loses fluids (particularly water).
Causes:
The major causes of dehydration include excessive sweating, fever, vomiting, diarrhea, and diuresis.
Signs and Symptoms:
Symptoms primarily include intense...
2.8K
Drug Dosing: Obese Patients
345
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
345
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
399
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
399
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
294
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
294


